Lilly, BI's Tradjenta ties generic rival in heart safety study by Carly Helfand Tuesday, June 11, 2019 Lilly and Boehringer have already shown that Tradjenta doesn’t hurt patients’ hearts. But the pair is back with even more supporting evidence.
